Neuroimaging in Dementia.

[1]  Clifford R. Jack,et al.  Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease , 2007, Neurobiology of Aging.

[2]  Clifford R Jack,et al.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. , 2007, Brain : a journal of neurology.

[3]  Clifford R Jack,et al.  Rates of cerebral atrophy differ in different degenerative pathologies. , 2006, Brain : a journal of neurology.

[4]  H. Engler,et al.  Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. , 2006, Brain : a journal of neurology.

[5]  G. E. Alexander,et al.  Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment , 2006, Neurobiology of Aging.

[6]  Gina N. LaRossa,et al.  [11C]PIB in a nondemented population , 2006, Neurology.

[7]  D. Birchall,et al.  Proton magnetic resonance spectroscopy in frontotemporal dementia , 2006, Journal of Neurology.

[8]  C. Rowe,et al.  O3-06-07 C-11 PIB PET amyloid imaging in aging and dementia , 2006, Alzheimer's & Dementia.

[9]  Jennifer L. Whitwell,et al.  Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. , 2006, Brain : a journal of neurology.

[10]  Sterling C. Johnson,et al.  The Influence of Alzheimer Disease Family History and Apolipoprotein E ε4 on Mesial Temporal Lobe Activation , 2006, The Journal of Neuroscience.

[11]  D. Skovronsky,et al.  Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  Felice Sun,et al.  Brain imaging evidence of preclinical Alzheimer's disease in normal aging , 2006, Annals of neurology.

[13]  K. Abe,et al.  Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex , 2006, Neuroreport.

[14]  Karl Herholz,et al.  18FDG PET in Vascular Dementia: Differentiation from Alzheimer's Disease Using Voxel-Based Multivariate Analysis , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  F. Mishkin,et al.  Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia , 2006, Neurology.

[16]  Alberto Pupi,et al.  Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer’s disease using FDG-PET , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  Clifford R Jack,et al.  Comparisons Between Alzheimer Disease, Frontotemporal Lobar Degeneration, and Normal Aging With Brain Mapping , 2005, Topics in magnetic resonance imaging : TMRI.

[18]  S. Rombouts,et al.  Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study , 2005, Human brain mapping.

[19]  S. DeKosky,et al.  Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Karsten Specht,et al.  Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography , 2005, Psychiatry Research: Neuroimaging.

[21]  C. Jack,et al.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.

[22]  Nick C Fox,et al.  Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. , 2005, Archives of neurology.

[23]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[24]  N. Fayed,et al.  Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. , 2005, The American journal of psychiatry.

[25]  C. Jack,et al.  DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment , 2005, Neurology.

[26]  L. Mosconi,et al.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  S. Gilman,et al.  Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing , 2005, Experimental Neurology.

[28]  J. S. Lee,et al.  18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  G. Frisoni,et al.  Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[30]  H C Charles,et al.  Impact of APOE in mild cognitive impairment , 2004, Neurology.

[31]  E G Tangalos,et al.  1H MR spectroscopy in common dementias , 2004, Neurology.

[32]  Stefan Poljansky,et al.  Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease , 2004, NeuroImage.

[33]  Nick C. Fox,et al.  Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates , 2004, NeuroImage.

[34]  Agneta Nordberg,et al.  PET imaging of amyloid in Alzheimer's disease , 2004, The Lancet Neurology.

[35]  Linda S Hynan,et al.  Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[37]  C. Jack,et al.  Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients , 2003, Neurology.

[38]  Kiralee M. Hayashi,et al.  Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.

[39]  M. Albert,et al.  fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[40]  D. Neary,et al.  Diagnostic value of high signal abnormalities on T2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias , 2002, Acta neurologica Scandinavica.

[41]  H J Testa,et al.  Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia , 2002, Acta neurologica Scandinavica.

[42]  C. Jack,et al.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.

[43]  B L Miller,et al.  Patterns of brain atrophy in frontotemporal dementia and semantic dementia , 2002, Neurology.

[44]  G. Small,et al.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[45]  Satoshi Minoshima,et al.  Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation , 2001, Annals of neurology.

[46]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[47]  M N Rossor,et al.  Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.

[48]  P Julin,et al.  Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[49]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[50]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[51]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[52]  Nick C Fox,et al.  Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. , 1996, Brain : a journal of neurology.